SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-17-016021
Filing Date
2017-09-18
Accepted
2017-09-18 17:05:05
Documents
4
Period of Report
2017-11-01
Effectiveness Date
2017-09-18

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dffn20170914_def14a.htm DEF 14A 199090
2 a2.jpg GRAPHIC 111549
3 a1.jpg GRAPHIC 165133
4 logo.jpg GRAPHIC 11595
  Complete submission text file 0001437749-17-016021.txt   597727
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37942 | Film No.: 171090391
SIC: 2834 Pharmaceutical Preparations